Compositions including antibiotics and methods for using same

A method for treating a corneal injury comprising:

• administering to a mammalian eye having a corneal injury a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic in the mammalian eye and a NSAID component in an amount effective, in combination with the quinolone component, to provide a reduction in paid caused by the corneal injury.

The method of claim 9 wherein the quinolone component is an ofloxacin component, the NSAID component is a ketorolac component, and the corneal injury is a corneal ulcer.

A method for treating an ocular infection comprising:

• administering to a mammalian eye having an infection caused by one or more pathogens a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic in the mammalian eye and a NSAID component in an amount effective to reduce the time needed to eliminate the infection relative to identically administering a similar composition without the NSAID component.

A method for treating an ocular infection comprising:

• administering to a mammalian including at least one surface;
• and
• an eye having an infection caused by one or more pathogens a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic in the mammalian eye and an NSAID component in an amount effective to at least inhibit the one or more pathogens from adhering to the surface.

A method for treating an ocular infection comprising:

• administering to a mammalian eye having an infection caused by one or more pathogens a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic in the mammalian eye and a NSAID component in an amount effective to inhibit colonization of the one or more pathogens in the mammalian eye.

A composition comprising:

• a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, the quinolone component in the compositions having fungistatic activity;
• a carrier component in an amount effective to act as a carrier for the quinolone component and the NSAID component in the composition, the carrier component being ophthalmically acceptable;
• wherein said composition contains substantially no additional components effective to act as a preservative.